Investment Stage: Series A
Portfolio 16
| Date | Name | Website | Total Raised | Location |
| 01.10.2025 | Axon Thera... | axontherapies.com | $32M | United Sta... |
| - | Just a mom... | necteromedical.com | - | - |
| - | levatherapy.com | - | - | |
| - | Caretaker ... | caretakermedical.net | $3.6M | United Sta... |
| - | Raydiant O... | raydiantoximetry.com | $13.5M | United Sta... |
| - | SmartShot | marrowaccess.com | - | United Sta... |
| - | Zafrens | zafrens.com | $29M | United Sta... |
| - | Cerapedics... | cerapedics.com | $89M | United Sta... |
| - | Venova Med... | venovamedical.com | $30M | - |
| - | Merck | merck.com | $700M | United Sta... |
Show more
Mentions in press and media 6
| Date | Title | Description |
| 01.10.2025 | Axon Therapies: $32 Million Series A Secured For Developing Heart Failure Treatments | Axon Therapies, a pioneering company in the medical device field, has announced the closure of an oversubscribed $32 million Series A funding round, focused on developing innovative treatments for heart failure. This funding round was co-le... |
| 26.09.2025 | Axon Therapies Raises $32M in Funding | Co-founder Zoar Engelman, PhD, appointed CEO of Axon Therapies Axon Therapeutics, a NYC-based clinical-stage medical device company, raised $32M in funding. The round was led by Earlybird Venture Capital and Santé Ventures, with participati... |
| 12.09.2024 | CorFlow Therapeutics Secures €44 Million to Revolutionize Heart Attack Treatment | CorFlow Therapeutics is on a mission. The Swiss company has just raised €44 million in a Series B funding round, co-led by Broadview Ventures and Panakes Partners. This influx of capital is not just a financial boost; it’s a lifeline for pa... |
| 12.09.2024 | CorFlow Therapeutics raises €44 million in Series B round | Headquarted in Baar (Zug), CorFlow’s Controlled Flow Infusion (CoFI) system is being developed to provide timely, accurate and consistent detection of Microvascular Obstruction (MVO) while patients are still in the catheter laboratory (cat... |
| 12.09.2024 | CorFlow Therapeutics raises €44 million in Series B round | Co-led by Broadview Ventures and Panakes Partners, CoFlow’s series B round received strong continued support from 415 Capital, its initial VC investor and largest shareholder. Merieux Equity Partners, Laerdal Million Lives Fund, Wellington... |
| 12.09.2024 | CorFlow Therapeutics: €44 Million (Series B) Raised For Advancing Drug Delivery Platform Related To Microvascular Obstruction In Heart Attack Patients | CorFlow Therapeutics AG announced that it has raised €44 million in Series B funding, co-led by Broadview Ventures and Panakes Partners with strong continued support from 415 Capital (CorFlow’s initial VC investor and largest shareholder). ... |